Elizabeth Nielson & Ingmar Gorman
Joe Flanders, Andrew Rose, Leah Gooch, David Gumpel
Thomson House, McGill University
3650 McTavish St
Montreal, H3A 1Y2 Quebec
*As of posting the intention is to offer this program in-person. In the event that public health policy does not allow us to offer it in person as of thirty-days prior to the event, it will be rescheduled for a later date—not moved to an online format.
Program Ticket: 3-Days October 23, 24, & 25 US$650
Program Ticket: 2-Days October 23 & 24 US$450
CE Certificates is available for an additional US$65
CME is available for an additional US$350
This workshop is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics. This interactive training includes role plays, demonstrations, case examples, and experiential learning opportunities.
This workshop has an enrollment limited to 70 participants. Lead trainers Drs Gorman & Nielson as well as 4 assisting trainers will be present. This workshop has been offered nationally and internationally over 10 times in the last 2 years and has routinely sold out and generated a waiting list. Upon completion, participants will be offered the opportunity to join the presenters’ google group with over 500 past program participants for networking and continued collaboration.
Friday and Saturday constitute “Psychedelics 101 & 102 for Clinicians” supplemented by an experiential day of mindfulness practices for psychedelic integration on Sunday. A limited number of Sunday only tickets are available for people who have previously attended 101 & 102. We strongly encourage participants to take the full 3-day workshop.
Psychedelics 101 (Friday): Your patients are curious and so are you: What is all this about psychedelics being used for treatment of addiction and trauma? This session gives an overview of psychedelic drugs, their history, and current research with MDMA and Psilocybin-assisted therapy. This program includes an overview of recent and current clinical trials, outcomes, legal status, and what it all means for the future of addiction and trauma treatment.
Psychedelics 102 (Saturday): This day introduces clinical skills for psychedelic harm reduction and integration work in the clinical setting. This program focuses on translating research findings into clinical practice including working with patients who are considering using psychedelics, actually using psychedelics, or have used them. Includes discussion of assessment and integration techniques, resources, and legal and ethical issues.
Mindfulness Skills for Integration (Sunday):
Mindfulness meditation practices offer an opportunity to practice integration of all non-ordinary states of consciousness, including psychedelic experiences. In this program, participants engage in a series of meditative experiences and integration techniques to cultivate an ongoing relationship with the profound insights of those states, also applicable to more ephemeral psychedelic experiences. Attendees will gain an understanding of how contemplative and mind-body practices can support patients in touching into and gently staying with experiences and insights of psychedelic experiences so that these might be further incorporated into the larger scope of life. The content and practice of mindfulness for psychedelic integration will be explored in a supportive, experiential space that allows participants to give voice to their own experience with non-verbal, inner directed guidance.
This course has been approved by the OPQ for 12 hours of continuing education credits, and the cost is included in the program price.
Continuing Education Credits for Health Professionals (CE)
Continuing Education credits are offered at an additional cost of $65 USD, payable to the presenters by credit card through a separate invoice.
For Physicians and Medical Professionals (CME)
CME accreditation is available at an additional cost of $350 USD, payable to the presenters by credit card through a separate invoice.
In support of improving patient care, this activity has been planned and implemented by Cine-Med and Medical Resource Association. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Ciné-Med designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.